Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2004 1
2005 1
2006 1
2007 1
2008 3
2009 2
2010 4
2011 4
2012 4
2013 5
2014 2
2015 3
2016 8
2017 3
2018 6
2019 12
2020 7
2021 2
2022 17
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.
Marshall AD, Willing AR, Kairouz A, Cunningham EB, Wheeler A, O'Brien N, Perera V, Ward JW, Hiebert L, Degenhardt L, Hajarizadeh B, Colledge S, Hickman M, Jawad D, Lazarus JV, Matthews GV, Scheibe A, Vickerman P, Dore GJ, Grebely J; Global HCV and HIV Treatment Restrictions Group. Marshall AD, et al. Lancet Gastroenterol Hepatol. 2024 Apr;9(4):366-382. doi: 10.1016/S2468-1253(23)00335-7. Epub 2024 Feb 15. Lancet Gastroenterol Hepatol. 2024. PMID: 38367631 Review.
Joint statement in support of hepatitis C human challenge studies.
Alter HJ, Barnes E, Biondi MJ, Cox AL, Eberts JD, Feld JJ, Liang TJ, Morrison J, Rice CM, Shoukry NH, Thomas DL, Van Gennip J, Weijer C; other signatories. Alter HJ, et al. Lancet Gastroenterol Hepatol. 2023 Nov;8(11):967-969. doi: 10.1016/S2468-1253(23)00314-X. Epub 2023 Sep 21. Lancet Gastroenterol Hepatol. 2023. PMID: 37742699 No abstract available.
Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015-2020.
Baliashvili D, Blumberg HM, Gandhi NR, Averhoff F, Benkeser D, Shadaker S, Gvinjilia L, Turdziladze A, Tukvadze N, Chincharauli M, Butsashvili M, Sharvadze L, Tsertsvadze T, Zarkua J, Kempker RR. Baliashvili D, et al. Among authors: butsashvili m. PLoS Med. 2023 May 4;20(5):e1004121. doi: 10.1371/journal.pmed.1004121. eCollection 2023 May. PLoS Med. 2023. PMID: 37141386 Free PMC article.
Economic evaluation of the Hepatitis C virus elimination program in the country of Georgia, 2015 to 2017.
Tskhomelidze I, Shadaker S, Kuchuloria T, Gvinjilia L, Butsashvili M, Nasrullah M, Gabunia T, Gamkrelidze A, Getia V, Sharvadze L, Tsertsvadze T, Zarqua J, Tsanava S, Handanagic S, Armstrong PA, Averhoff F, Vickerman P, Walker JG. Tskhomelidze I, et al. Among authors: butsashvili m. Liver Int. 2023 Mar;43(3):558-568. doi: 10.1111/liv.15431. Epub 2022 Oct 4. Liver Int. 2023. PMID: 36129625 Free PMC article.
Barriers of linkage to HCV viremia testing among people who inject drugs in Georgia.
Butsashvili M, Abzianidze T, Kamkamidze G, Gulbiani L, Gvinjilia L, Kuchuloria T, Tskhomelidze I, Gogia M, Tsereteli M, Miollany V, Kikvidze T, Shadaker S, Nasrullah M, Averhoff F. Butsashvili M, et al. Subst Abuse Treat Prev Policy. 2022 Mar 28;17(1):23. doi: 10.1186/s13011-022-00438-6. Subst Abuse Treat Prev Policy. 2022. PMID: 35346265 Free PMC article.
89 results